A citation-based method for searching scientific literature

Paul Rutgeerts, William J Sandborn, Brian G Feagan, Walter Reinisch, Allan Olson, Jewel Johanns, Suzanne Travers, Daniel Rachmilewitz, Stephen B Hanauer, Gary R Lichtenstein, Willem J S de Villiers, Daniel Present, Bruce E Sands, Jean Frédéric Colombel. N Engl J Med 2005
Times Cited: 2629







List of co-cited articles
522 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis.
William J Sandborn, Gert van Assche, Walter Reinisch, Jean-Frederic Colombel, Geert D'Haens, Douglas C Wolf, Martina Kron, Mary Beth Tighe, Andreas Lazar, Roopal B Thakkar. Gastroenterology 2012
782
35

Vedolizumab as induction and maintenance therapy for ulcerative colitis.
Brian G Feagan, Paul Rutgeerts, Bruce E Sands, Stephen Hanauer, Jean-Frédéric Colombel, William J Sandborn, Gert Van Assche, Jeffrey Axler, Hyo-Jong Kim, Silvio Danese,[...]. N Engl J Med 2013
35

Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.
William J Sandborn, Chinyu Su, Bruce E Sands, Geert R D'Haens, Séverine Vermeire, Stefan Schreiber, Silvio Danese, Brian G Feagan, Walter Reinisch, Wojciech Niezychowski,[...]. N Engl J Med 2017
660
25

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial.
Walter Reinisch, William J Sandborn, Daniel W Hommes, Geert D'Haens, Stephen Hanauer, Stefan Schreiber, Remo Panaccione, Richard N Fedorak, Mary Beth Tighe, Bidan Huang,[...]. Gut 2011
574
23

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.
Stephen B Hanauer, Brian G Feagan, Gary R Lichtenstein, Lloyd F Mayer, S Schreiber, Jean Frederic Colombel, Daniel Rachmilewitz, Douglas C Wolf, Allan Olson, Weihang Bao,[...]. Lancet 2002
22

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
Bruce E Sands, William J Sandborn, Remo Panaccione, Christopher D O'Brien, Hongyan Zhang, Jewel Johanns, Omoniyi J Adedokun, Katherine Li, Laurent Peyrin-Biroulet, Gert Van Assche,[...]. N Engl J Med 2019
342
22

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
Bruce E Sands, Laurent Peyrin-Biroulet, Edward V Loftus, Silvio Danese, Jean-Frédéric Colombel, Murat Törüner, Laimas Jonaitis, Brihad Abhyankar, Jingjing Chen, Raquel Rogers,[...]. N Engl J Med 2019
231
20

Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.
William J Sandborn, Brian G Feagan, Colleen Marano, Hongyan Zhang, Richard Strauss, Jewel Johanns, Omoniyi J Adedokun, Cynthia Guzzo, Jean-Frederic Colombel, Walter Reinisch,[...]. Gastroenterology 2014
538
19

Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis.
William J Sandborn, Brian G Feagan, Colleen Marano, Hongyan Zhang, Richard Strauss, Jewel Johanns, Omoniyi J Adedokun, Cynthia Guzzo, Jean-Frederic Colombel, Walter Reinisch,[...]. Gastroenterology 2014
460
17


Ulcerative colitis.
Ryan Ungaro, Saurabh Mehandru, Patrick B Allen, Laurent Peyrin-Biroulet, Jean-Frédéric Colombel. Lancet 2017
16

Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis.
Remo Panaccione, Subrata Ghosh, Stephen Middleton, Juan R Márquez, Boyd B Scott, Laurence Flint, Hubert J F van Hoogstraten, Annie C Chen, Hanzhe Zheng, Silvio Danese,[...]. Gastroenterology 2014
561
14

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management.
Marcus Harbord, Rami Eliakim, Dominik Bettenworth, Konstantinos Karmiris, Konstantinos Katsanos, Uri Kopylov, Torsten Kucharzik, Tamás Molnár, Tim Raine, Shaji Sebastian,[...]. J Crohns Colitis 2017
579
14

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.
Dan Turner, Amanda Ricciuto, Ayanna Lewis, Ferdinando D'Amico, Jasbir Dhaliwal, Anne M Griffiths, Dominik Bettenworth, William J Sandborn, Bruce E Sands, Walter Reinisch,[...]. Gastroenterology 2021
236
14

ACG Clinical Guideline: Ulcerative Colitis in Adults.
David T Rubin, Ashwin N Ananthakrishnan, Corey A Siegel, Bryan G Sauer, Millie D Long. Am J Gastroenterol 2019
435
13

Infliximab, azathioprine, or combination therapy for Crohn's disease.
Jean Frédéric Colombel, William J Sandborn, Walter Reinisch, Gerassimos J Mantzaris, Asher Kornbluth, Daniel Rachmilewitz, Simon Lichtiger, Geert D'Haens, Robert H Diamond, Delma L Broussard,[...]. N Engl J Med 2010
11

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial.
Jean-Frédéric Colombel, William J Sandborn, Paul Rutgeerts, Robert Enns, Stephen B Hanauer, Remo Panaccione, Stefan Schreiber, Dan Byczkowski, Ju Li, Jeffrey D Kent,[...]. Gastroenterology 2007
10

Vedolizumab as induction and maintenance therapy for Crohn's disease.
William J Sandborn, Brian G Feagan, Paul Rutgeerts, Stephen Hanauer, Jean-Frédéric Colombel, Bruce E Sands, Milan Lukas, Richard N Fedorak, Scott Lee, Brian Bressler,[...]. N Engl J Med 2013
10

Review article: loss of response to anti-TNF treatments in Crohn's disease.
S Ben-Horin, Y Chowers. Aliment Pharmacol Ther 2011
385
10

First- and Second-Line Pharmacotherapies for Patients With Moderate to Severely Active Ulcerative Colitis: An Updated Network Meta-Analysis.
Siddharth Singh, Mohammad Hassan Murad, Mathurin Fumery, Parambir S Dulai, William J Sandborn. Clin Gastroenterol Hepatol 2020
92
10

Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
Brian G Feagan, William J Sandborn, Christopher Gasink, Douglas Jacobstein, Yinghua Lang, Joshua R Friedman, Marion A Blank, Jewel Johanns, Long-Long Gao, Ye Miao,[...]. N Engl J Med 2016
821
9

Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management.
Giulia Roda, Bindia Jharap, Narula Neeraj, Jean-Frederic Colombel. Clin Transl Gastroenterol 2016
285
9

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders.
Fernando Magro, Paolo Gionchetti, Rami Eliakim, Sandro Ardizzone, Alessandro Armuzzi, Manuel Barreiro-de Acosta, Johan Burisch, Krisztina B Gecse, Ailsa L Hart, Pieter Hindryckx,[...]. J Crohns Colitis 2017
790
8

Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial.
Kristin K Jørgensen, Inge C Olsen, Guro L Goll, Merete Lorentzen, Nils Bolstad, Espen A Haavardsholm, Knut E A Lundin, Cato Mørk, Jørgen Jahnsen, Tore K Kvien. Lancet 2017
458
8

Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis.
William J Sandborn, Subrata Ghosh, Julian Panes, Ivana Vranic, Chinyu Su, Samantha Rousell, Wojciech Niezychowski. N Engl J Med 2012
519
8

Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study.
Nicholas A Kennedy, Graham A Heap, Harry D Green, Benjamin Hamilton, Claire Bewshea, Gareth J Walker, Amanda Thomas, Rachel Nice, Mandy H Perry, Sonia Bouri,[...]. Lancet Gastroenterol Hepatol 2019
235
8

Ulcerative colitis.
Taku Kobayashi, Britta Siegmund, Catherine Le Berre, Shu Chen Wei, Marc Ferrante, Bo Shen, Charles N Bernstein, Silvio Danese, Laurent Peyrin-Biroulet, Toshifumi Hibi. Nat Rev Dis Primers 2020
175
8

A reproducible grading scale for histological assessment of inflammation in ulcerative colitis.
K Geboes, R Riddell, A Ost, B Jensfelt, T Persson, R Löfberg. Gut 2000
538
7

Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.
Jean Frédéric Colombel, Paul Rutgeerts, Walter Reinisch, Dirk Esser, Yanxin Wang, Yinghua Lang, Colleen W Marano, Richard Strauss, Björn J Oddens, Brian G Feagan,[...]. Gastroenterology 2011
614
7

Infliximab for the treatment of fistulas in patients with Crohn's disease.
D H Present, P Rutgeerts, S Targan, S B Hanauer, L Mayer, R A van Hogezand, D K Podolsky, B E Sands, T Braakman, K L DeWoody,[...]. N Engl J Med 1999
7

Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority study.
Byong Duk Ye, Marina Pesegova, Olga Alexeeva, Marina Osipenko, Adi Lahat, Andriy Dorofeyev, Sigal Fishman, Olena Levchenko, Jae Hee Cheon, Maria Lia Scribano,[...]. Lancet 2019
93
7

Infliximab maintenance therapy for fistulizing Crohn's disease.
Bruce E Sands, Frank H Anderson, Charles N Bernstein, William Y Chey, Brian G Feagan, Richard N Fedorak, Michael A Kamm, Joshua R Korzenik, Bret A Lashner, Jane E Onken,[...]. N Engl J Med 2004
7

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.
Christopher Andrew Lamb, Nicholas A Kennedy, Tim Raine, Philip Anthony Hendy, Philip J Smith, Jimmy K Limdi, Bu'Hussain Hayee, Miranda C E Lomer, Gareth C Parkes, Christian Selinger,[...]. Gut 2019
545
7

AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis.
Joseph D Feuerstein, Kim L Isaacs, Yecheskel Schneider, Shazia Mehmood Siddique, Yngve Falck-Ytter, Siddharth Singh. Gastroenterology 2020
123
6

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.
S R Targan, S B Hanauer, S J van Deventer, L Mayer, D H Present, T Braakman, K L DeWoody, T F Schaible, P J Rutgeerts. N Engl J Med 1997
6

Association between serum concentration of infliximab and efficacy in adult patients with ulcerative colitis.
Omoniyi J Adedokun, William J Sandborn, Brian G Feagan, Paul Rutgeerts, Zhenhua Xu, Colleen W Marano, Jewel Johanns, Honghui Zhou, Hugh M Davis, Freddy Cornillie,[...]. Gastroenterology 2014
234
6

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.
Mark S Silverberg, Jack Satsangi, Tariq Ahmad, Ian D R Arnott, Charles N Bernstein, Steven R Brant, Renzo Caprilli, Jean-Frédéric Colombel, Christoph Gasche, Karel Geboes,[...]. Can J Gastroenterol 2005
6

Observational study on the efficacy of adalimumab for the treatment of ulcerative colitis and predictors of outcome.
Orlando García-Bosch, Javier P Gisbert, Alex Cañas-Ventura, Olga Merino, José L Cabriada, Valle García-Sánchez, Ana Gutiérrez, Pilar Nos, Mireia Peñalva, Joaquin Hinojosa,[...]. J Crohns Colitis 2013
66
9

Ulcerative colitis.
Silvio Danese, Claudio Fiocchi. N Engl J Med 2011
751
6

Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease.
Magali Lemaitre, Julien Kirchgesner, Annie Rudnichi, Fabrice Carrat, Mahmoud Zureik, Franck Carbonnel, Rosemary Dray-Spira. JAMA 2017
260
6

Ulcerative colitis as a progressive disease: the forgotten evidence.
Joana Torres, Vincent Billioud, David B Sachar, Laurent Peyrin-Biroulet, Jean-Frédéric Colombel. Inflamm Bowel Dis 2012
137
6

Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis.
Yasuo Suzuki, Satoshi Motoya, Hiroyuki Hanai, Takayuki Matsumoto, Toshifumi Hibi, Anne M Robinson, Nael M Mostafa, Jingdong Chao, Vipin Arora, Anne Camez,[...]. J Gastroenterol 2014
102
6

Efficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerative Colitis.
William J Sandborn, Filip Baert, Silvio Danese, Željko Krznarić, Taku Kobayashi, Xiaopan Yao, Jingjing Chen, Maria Rosario, Siddharth Bhatia, Krisztina Kisfalvi,[...]. Gastroenterology 2020
67
8

Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspects.
Matthieu Allez, Konstantinos Karmiris, Edouard Louis, Gert Van Assche, Shomron Ben-Horin, Amir Klein, Janneke Van der Woude, Filip Baert, Rami Eliakim, Konstantinos Katsanos,[...]. J Crohns Colitis 2010
226
5

Efficacy and Safety of the Biosimilar Infliximab CT-P13 Treatment in Inflammatory Bowel Diseases: A Prospective, Multicentre, Nationwide Cohort.
Krisztina B Gecse, Barbara D Lovász, Klaudia Farkas, János Banai, László Bene, Beáta Gasztonyi, Petra Anna Golovics, Tünde Kristóf, László Lakatos, Ágnes Anna Csontos,[...]. J Crohns Colitis 2016
139
5

The safety of vedolizumab for ulcerative colitis and Crohn's disease.
Jean-Frédéric Colombel, Bruce E Sands, Paul Rutgeerts, William Sandborn, Silvio Danese, Geert D'Haens, Remo Panaccione, Edward V Loftus, Serap Sankoh, Irving Fox,[...]. Gut 2017
426
5

Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD.
Marco Daperno, Geert D'Haens, Gert Van Assche, Filip Baert, Philippe Bulois, Vincent Maunoury, Raffaello Sostegni, Rodolfo Rocca, Angelo Pera, Annemie Gevers,[...]. Gastrointest Endosc 2004
897
5

Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis.
William J Sandborn, Marc Ferrante, Bal R Bhandari, Elina Berliba, Brian G Feagan, Toshifumi Hibi, Jay L Tuttle, Paul Klekotka, Stuart Friedrich, Michael Durante,[...]. Gastroenterology 2020
55
9

Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
William J Sandborn, Christopher Gasink, Long-Long Gao, Marion A Blank, Jewel Johanns, Cynthia Guzzo, Bruce E Sands, Stephen B Hanauer, Stephan Targan, Paul Rutgeerts,[...]. N Engl J Med 2012
731
5

The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation.
K T Park, Orna G Ehrlich, John I Allen, Perry Meadows, Eva M Szigethy, Kim Henrichsen, Sandra C Kim, Rachel C Lawton, Sean M Murphy, Miguel Regueiro,[...]. Inflamm Bowel Dis 2020
116
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.